EUVIMEDEUVIMED entdecken
Crossref

Regulatory effects of kaempferol and silymarin on miRNAs and cell cycle/apoptosis pathways in chronic myeloid leukemia cells

Kutay Bulut, Sunde Yılmaz Süslüer

Developments and Experiments in Health and Medicine · 29.04.2026 · 40 (2) · 184-198

DOI: 10.18614/dehm.1760340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developments and Experiments in Health and Medicine, online erschienen am 29.04.2026. Verfasst von Kutay Bulut und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder characterized by the BCR-ABL fusion gene, which leads to constitutive tyrosine kinase activity and results in uncontrolled cell proliferation. This genetic alteration causes increased cell growth and suppression of apoptosis. The aim of this study is to investigate the effects of the natural compounds silymarinand kaempferol on the expression of 88 cancer-related miRNAs and genes associated with apoptosis and cell cycle regulation in the K562 CML cell line.

Methods

K562 cells were treated with the IC₅₀ doses of silymarin and kaempferol for 48 hours. Following total RNA (including miRNA) isolation, the expression levels of 88 miRNAs as well as apoptosis- and cell cycle-related genes were evaluated using quantitative PCR. Expression changes were analyzed using the 2^-ΔΔCT method, and fold changes ≥2 or ≤−2 were considered statistically significant (p<0.05).

Results

Both compounds significantly altered the expression of several miRNAs. Tumor-suppressor miRNAs were generally upregulated, while oncogenic miRNAs such as miR-21 were downregulated. Among apoptosis-related genes, CASP3, BAX and TP53 were upregulated, whereas BCL2 was downregulated. Additionally, cell cycle regulatory genes such as CDK1 and CCNB1 were also found to be downregulated.

Conclusion

Kaempferol and silymarin exhibited anticancer potential in CML by modulating miRNA profiles and regulating genes involved in apoptosis and cell cycle processes. These findings suggest that both compounds may serve as potential adjunct therapeutic agents in the treatment of Chronic Myeloid Leukemia.

Zitieren

APA

Bulut, K., & Süslüer, S. Y. (2026). Regulatory effects of kaempferol and silymarin on miRNAs and cell cycle/apoptosis pathways in chronic myeloid leukemia cells. Developments and Experiments in Health and Medicine, 40(2), 184-198. https://doi.org/10.18614/dehm.1760340

Vancouver

Bulut K, Süslüer SY. Regulatory effects of kaempferol and silymarin on miRNAs and cell cycle/apoptosis pathways in chronic myeloid leukemia cells. Developments and Experiments in Health and Medicine. 2026;40(2):184-198. doi:10.18614/dehm.1760340

BibTeX
@article{Bulut2026,
  author = {Bulut, Kutay and Süslüer, Sunde Yılmaz},
  title = {Regulatory effects of kaempferol and silymarin on miRNAs and cell cycle/apoptosis pathways in chronic myeloid leukemia cells},
  journal = {Developments and Experiments in Health and Medicine},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {184--198},
  doi = {10.18614/dehm.1760340}
}
Kostenlos starten →